Login

Centessa Pharmaceuticals plc SEC Filings

Filed On Filing
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 SCHEDULE 13G/A
12 Aug 2026 SCHEDULE 13G/A
04 Aug 2026 SCHEDULE 13G/A
08 Jul 2026 SCHEDULE 13G/A
06 Jul 2026 15-12G
26 Jun 2026 SCHEDULE 13D/A
24 Jun 2026 SCHEDULE 13D
24 Jun 2026 Form 4: Medicxi Ventures Management (Jersey) Ltd, 10% owner and 9 others

Sold 19,963,157 shares

24 Jun 2026 Form 4: Index Ventures Life Vi (JERSEY) L.p., 10% owner and 2 others

Sold 9,961,789 shares

24 Jun 2026 Form 4: Hussain Iqbal J, Chief Legal Officer

Returned 123,145 shares to the issuer · Disposed of 1,253,338 Share Option (right to buy) (Disposition to Issuer)

24 Jun 2026 Form 4: Bush Tia L, Chief Technology & Quality Ofc

Returned 147,954 shares to the issuer · Disposed of 937,733 Share Option (right to buy) (Disposition to Issuer)

24 Jun 2026 Form 4: Crowley John J, Chief Financial Officer

Returned 45,000 shares to the issuer · Disposed of 1,031,000 Share Option (right to buy) (Disposition to Issuer)

24 Jun 2026 Form 4: Anderson Karen M., Chief People Officer

Returned 62,085 shares to the issuer · Disposed of 424,260 Share Option (right to buy) (Disposition to Issuer)

24 Jun 2026 Form 4: Deferiere Raphael, Chief Accounting Officer

Returned 11,000 shares to the issuer · Disposed of 207,000 Share Option (right to buy) (Disposition to Issuer)

24 Jun 2026 Form 4: Kanes Stephen, Chief Medical Officer

Returned 120,000 shares to the issuer · Disposed of 500,000 Share Option (right to buy) (Disposition to Issuer)

24 Jun 2026 Form 4: Accardi Mario Alberto, Director

Returned 243,282 shares to the issuer · Disposed of 566,425 Share Option (right to buy) (Disposition to Issuer)

24 Jun 2026 Form 4: De Rubertis Francesco, Director

Returned 19,963,157 shares to the issuer

24 Jun 2026 Form 4: Hedley Mary Lynne, Director

Disposed of 392,474 Share Option (right to buy) (Disposition to Issuer)

24 Jun 2026 Form 4: Goyal Arjun, Director

Returned 462,585 shares to the issuer · Disposed of 248,570 Share Option (right to buy) (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support